Es gab 50 kürzliche Insider-Transaktionen für Pfizer Inc. (PFE), darunter 29 Käufe und 21 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $64.79M und die gesamten Insider-Verkäufe auf $33.15M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Boshoff Christoffel, Mcdermott Michael, Bourla Albert. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — PFE
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2030-02-23 |
Boshoff Christoffel |
Executive Vice President |
Veräußerung |
17,984 |
$42.30 |
$760.72K |
- |
| 2029-02-24 |
Boshoff Christoffel |
Executive Vice President |
Veräußerung |
10,222 |
$45.96 |
$469.8K |
- |
| 2028-02-25 |
Boshoff Christoffel |
Executive Vice President |
Veräußerung |
16,688 |
$33.82 |
$564.39K |
- |
| 2028-02-25 |
Mcdermott Michael |
Executive Vice President |
Veräußerung |
32,769 |
$33.82 |
$1.11M |
- |
| 2027-02-27 |
Boshoff Christoffel |
Executive Vice President |
Veräußerung |
21,127 |
$31.31 |
$661.49K |
- |
| 2027-02-27 |
Mcdermott Michael |
Executive Vice President |
Veräußerung |
41,485 |
$31.31 |
$1.3M |
- |
| 2026-03-31 |
Bourla Albert |
Chairman & CEO |
RSU-Zuteilung |
21 |
- |
- |
759,049 |
| 2026-03-27 |
Narayen Shantanu |
Director |
RSU-Zuteilung |
1,849 |
- |
- |
187,925 |
| 2026-03-27 |
Taraporevala Cyrus |
Director |
RSU-Zuteilung |
1,387 |
- |
- |
27,140 |
| 2026-03-27 |
Quincey James |
Director |
RSU-Zuteilung |
1,433 |
- |
- |
77,318 |
| 2026-03-27 |
Smith James C |
Director |
RSU-Zuteilung |
1,664 |
- |
- |
170,425 |
| 2026-03-27 |
Echevarria Joseph |
Director |
RSU-Zuteilung |
1,710 |
- |
- |
153,398 |
| 2026-03-27 |
Buckley Mortimer J |
Director |
RSU-Zuteilung |
1,387 |
- |
- |
16,705 |
| 2026-03-13 |
Bourla Albert |
Chairman & CEO |
RSU-Zuteilung |
1,630 |
- |
- |
759,400 |
| 2026-03-04 |
Damico Jennifer B. |
SVP & Controller |
RSU-Steuereinbehalt |
826 |
$26.62 |
$21.99K |
32,934 |
| 2026-03-03 |
Denton David M |
Chief Financial Officer & EVP |
RSU-Zuteilung |
216,537 |
$26.58 |
$5.76M |
216,537 |
| 2026-03-03 |
Fonseca Lidia |
Executive Vice President |
RSU-Zuteilung |
82,284 |
$26.58 |
$2.19M |
82,284 |
| 2026-03-03 |
Lankler Douglas M |
Executive Vice President |
RSU-Zuteilung |
194,883 |
$26.58 |
$5.18M |
194,883 |
| 2026-03-03 |
Bourla Albert |
Chairman & CEO |
RSU-Zuteilung |
708,666 |
$26.58 |
$18.84M |
708,666 |
| 2026-03-03 |
Damico Jennifer B. |
SVP & Controller |
RSU-Zuteilung |
22,638 |
$26.58 |
$601.72K |
22,638 |
| 2026-03-03 |
Sahni Payal |
Executive Vice President |
RSU-Zuteilung |
108,268 |
$26.58 |
$2.88M |
108,268 |
| 2026-03-03 |
Malik Aamir |
Executive Vice President |
RSU-Zuteilung |
194,883 |
$26.58 |
$5.18M |
194,883 |
| 2026-03-03 |
Mcdermott Michael |
Executive Vice President |
RSU-Zuteilung |
151,576 |
$26.58 |
$4.03M |
151,576 |
| 2026-03-03 |
Boshoff Christoffel |
President, R&d |
RSU-Zuteilung |
259,844 |
$26.58 |
$6.91M |
259,844 |
| 2026-03-03 |
De Germay Alexandre |
Executive Vice President |
RSU-Zuteilung |
194,883 |
$26.58 |
$5.18M |
194,883 |
| 2026-03-03 |
Baum Andrew |
Executive Vice President |
RSU-Zuteilung |
303,151 |
$26.58 |
$8.06M |
303,151 |
| 2026-02-28 |
Boshoff Christoffel |
Executive Vice President |
Veräußerung |
12,009 |
$38.71 |
$464.87K |
- |
| 2026-02-28 |
Mcdermott Michael |
Executive Vice President |
Veräußerung |
16,011 |
$38.71 |
$619.79K |
- |
| 2026-02-27 |
Damico Jennifer B. |
SVP & Controller |
RSU-Steuereinbehalt |
655 |
$27.65 |
$18.11K |
12,041 |
| 2026-02-26 |
Mcdermott Michael |
Executive Vice President |
RSU-Steuereinbehalt |
3,503 |
$27.10 |
$94.93K |
74,308 |
| 2026-02-25 |
Fonseca Lidia |
Executive Vice President |
Optionsausübung (Verkauf) |
56,888 |
$33.82 |
$1.92M |
- |
| 2026-02-25 |
Lankler Douglas M |
Executive Vice President |
Optionsausübung (Verkauf) |
122,907 |
$33.82 |
$4.16M |
- |
| 2026-02-25 |
Bourla Albert |
Chairman & CEO |
Optionsausübung (Verkauf) |
491,626 |
$33.82 |
$16.63M |
- |
| 2026-02-25 |
Damico Jennifer B. |
SVP & Controller |
Optionsausübung (Verkauf) |
17,558 |
$33.82 |
$593.81K |
- |
| 2026-02-25 |
Sahni Payal |
Executive Vice President |
Optionsausübung (Verkauf) |
56,888 |
$33.82 |
$1.92M |
- |
| 2026-02-25 |
Mcdermott Michael |
Executive Vice President |
Optionsausübung (Verkauf) |
37,925 |
$33.82 |
$1.28M |
- |
| 2026-02-25 |
Boshoff Christoffel |
President, R&d |
RSU-Steuereinbehalt |
6,833 |
$27.09 |
$185.11K |
161,379 |
| 2026-02-23 |
Damico Jennifer B. |
SVP & Controller |
RSU-Steuereinbehalt |
419 |
$27.06 |
$11.34K |
12,186 |
| 2026-02-23 |
Boshoff Christoffel |
President, R&d |
RSU-Steuereinbehalt |
816 |
$27.06 |
$22.08K |
154,829 |
| 2026-02-12 |
Bourla Albert |
Chairman & CEO |
RSU-Zuteilung |
2,883 |
- |
- |
757,286 |
| 2026-01-30 |
Boshoff Christoffel |
President, R&d |
RSU-Steuereinbehalt |
12,887 |
$26.44 |
$340.73K |
155,645 |
| 2026-01-14 |
Bourla Albert |
Chairman & CEO |
RSU-Zuteilung |
79 |
- |
- |
743,136 |
| 2025-12-31 |
Narayen Shantanu |
Director |
RSU-Zuteilung |
2,008 |
- |
- |
183,164 |
| 2025-12-31 |
Taraporevala Cyrus |
Director |
RSU-Zuteilung |
1,506 |
- |
- |
25,350 |
| 2025-12-31 |
Quincey James |
Director |
RSU-Zuteilung |
1,556 |
- |
- |
74,697 |
| 2025-12-31 |
Bourla Albert |
Chairman & CEO |
RSU-Zuteilung |
24 |
- |
- |
743,147 |
| 2025-12-31 |
Smith James C |
Director |
RSU-Zuteilung |
1,807 |
- |
- |
166,120 |
| 2025-12-31 |
Echevarria Joseph |
Director |
RSU-Zuteilung |
1,857 |
- |
- |
149,314 |
| 2025-12-31 |
Buckley Mortimer J |
Director |
RSU-Zuteilung |
1,506 |
- |
- |
15,078 |
| 2025-12-15 |
Bourla Albert |
Chairman & CEO |
RSU-Zuteilung |
23 |
- |
- |
742,986 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
